HEALTH QUESTIONS / LIMITS OF PROOF
Weight changes and cell changes answer different treatment questions
Weight, blood sugar, infection deaths, and skin were tested separately. The measured change sets the limit on each treatment claim.
Retatrutide changed weight and sugar readings during early tests
Early studies followed people for limited periods rather than many years. Trials measured lower weight and blood-sugar test readings [3][4][5]. A smaller study used MRI scans to measure liver-fat loss. Retatrutide affects GIP, GLP-1, and glucagon, hormones helping the body handle food. Those early changes don't settle your lasting health benefits. Retatrutide is still under study and lacks medicine approval.
Three hormone actions help explain retatrutide trial findings
Laboratory responses don't show lasting health effects in patients. GIP and GLP-1 help control hunger and release insulin. Insulin helps sugar move from blood into cells. Glucagon helps release stored energy for the body to use. Cell tests found retatrutide attached where these hormones act, with unequal responses [2]. The explanation cannot settle your long-term treatment benefits.
Unchecked vials do not carry the safeguards of a trial
Trial supplies were checked for strength, contents, and possible germs. That assurance doesn't come with a research vial's name. Purity also remains a concern outside the trials. DQ Peptides gives no plan for mixing retatrutide or treating you. A label can't show that the contents match the trial material.
The cited retatrutide papers describe an unapproved possible medicine
Early and middle-stage papers describe retatrutide without FDA medicine approval [1][4][5][6]. That is the approval status reported in those studies. These papers don't show whether approval has changed since publication. Their dates are shown in the references for your check. The evidence here cannot confirm today's approval status. A research result alone isn't permission to sell a medicine.
MOTS-c muscle improvements were tested in animals, not treated people
The main treatment findings come from mice and laboratory-grown cells. Studies connected cell energy changes with muscle sugar use and performance [8][10][11][12]. Supplied MOTS-c improved some running, walking, and grip tests in mice. Researchers haven't shown those treatment benefits in people. The evidence also doesn't prove slower human aging for you.
MOTS-c human side-effect rates have not been established
No fair trial here checked side effects in treated people. How often those effects happen remains unknown. Your risks also include wrong contents, impurities, and possible germs. The research label gives no answer about those risks. A mouse study can't show how often people would be harmed.
Permission to sell research material does not approve human treatment
In these studies, MOTS-c still lacks FDA approval for people. Research material is intended for tests in a lab. Sale for that purpose doesn't approve giving it to people. Your supplies also lack the usual medicine checks. MOTS-c is banned under elite-sport rules.
Thymosin Alpha-1 has overseas medical use without United States approval
Thymosin Alpha-1 affects immune cells that recognize and fight threats. The peptide is linked with a gland called the thymus. The manufactured form is called thymalfasin. A review describes overseas medicine approvals [14]. Approval to sell the medicine is absent in the United States. Approval in another country cannot show permission where you live.
The biggest Thymosin Alpha-1 infection test left a survival benefit unproved
Sepsis involves infection causing a dangerous reaction throughout the body. TESTS studied 1,106 adults across twenty-two centers. Chance set treatments, hidden from patients and staff. By day twenty-eight, deaths were 23.4% with Thymosin Alpha-1. Deaths were 24.1% with placebo, containing no active medicine [13]. Chance could explain the difference, so a survival benefit remained unproved.
Small GHK-Cu skin findings cannot prove benefits from shots
Small skin tests and a mixed-product hair trial leave major limits [18][20]. Laboratory work linked GHK-Cu with cells making and repairing supporting tissue [19][21]. The hair trial tested GHK mixed with another ingredient. Neither finding proved renewed youth throughout the body. Your possible benefit from shots remains unproved.
Skin appearance and cell tests do not measure human aging
Small skin groups and laboratory cell tests provide limited evidence [18][19][21]. Researchers measured skin appearance or copies of gene instructions. Genes are the instructions telling cells how to grow and work. Those tests didn't show that people aged more slowly. They also didn't show that anyone lived longer.
Copper and the cream ingredients can change which form reaches skin
GHK has three linked amino acids, the pieces making proteins. GHK-Cu is GHK with copper attached. Many repair findings concern GHK-Cu, so the forms aren't interchangeable. A cream's other ingredients also affect what reaches skin [18][21]. Strong acidity can disturb copper's attachment to GHK. The skin barrier may then limit entry even when the attachment remains. Your product's name doesn't settle either question.